speb/financial-data huggingface dataset:
ICCM balance_sheet (annual, 2023-12-31) — Common Stock Equity: 12163000.00
ICCM cash_flow (annual, 2023-12-31) — Common Stock Issuance: 83000.00
ICCM income_statement (annual, 2023-12-31) — Cost Of Revenue: 1929000.00
ICCM balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 2282000.00
ICCM balance_sheet (annual, 2023-12-31) — Current Assets: 14184000.00
ICCM balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 223000.00
ICCM balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 223000.00
ICCM balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 187000.00
ICCM balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 187000.00
ICCM balance_sheet (annual, 2023-12-31) — Current Liabilities: 3871000.00
ICCM balance_sheet (annual, 2023-12-31) — Current Provisions: 677000.00
ICCM cash_flow (annual, 2023-12-31) — Depreciation: 323000.00
ICCM cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 323000.00
ICCM cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 323000.00
ICCM income_statement (annual, 2023-12-31) — Diluted Average Shares: 1521267.00
ICCM income_statement (annual, 2023-12-31) — Diluted EPS: -9.60
ICCM income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -14652000.00
ICCM income_statement (annual, 2023-12-31) — EBIT: -15576000.00
ICCM income_statement (annual, 2023-12-31) — EBITDA: -15253000.00
ICCM cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 25000.00
ICCM cash_flow (annual, 2023-12-31) — End Cash Position: 10533000.00
ICCM cash_flow (annual, 2023-12-31) — Financing Cash Flow: 83000.00
ICCM balance_sheet (annual, 2023-12-31) — Finished Goods: 568000.00
ICCM cash_flow (annual, 2023-12-31) — Free Cash Flow: -13030000.00
ICCM income_statement (annual, 2023-12-31) — General And Administrative Expense: 7392000.00
ICCM balance_sheet (annual, 2023-12-31) — Gross PPE: 3411000.00
ICCM income_statement (annual, 2023-12-31) — Gross Profit: 1300000.00
ICCM balance_sheet (annual, 2023-12-31) — Inventory: 2275000.00
ICCM balance_sheet (annual, 2023-12-31) — Invested Capital: 12163000.00
ICCM cash_flow (annual, 2023-12-31) — Investing Cash Flow: -684000.00
ICCM cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 83000.00
ICCM cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
ICCM balance_sheet (annual, 2023-12-31) — Leases: 209000.00
ICCM balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 376000.00
ICCM balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 376000.00
ICCM cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
ICCM cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
ICCM balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 558000.00
ICCM cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 83000.00
ICCM cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -25000.00
ICCM income_statement (annual, 2023-12-31) — Net Income: -14652000.00
ICCM income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -14652000.00
ICCM income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -14652000.00
ICCM income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -14652000.00
ICCM income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -14652000.00
ICCM cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -14652000.00
ICCM income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -14652000.00
ICCM income_statement (annual, 2023-12-31) — Net Interest Income: 924000.00
ICCM cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -500000.00
ICCM cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
ICCM cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
ICCM income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 924000.00
ICCM cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 296000.00
ICCM balance_sheet (annual, 2023-12-31) — Net PPE: 2192000.00
ICCM cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -480000.00
ICCM balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 12163000.00
ICCM income_statement (annual, 2023-12-31) — Normalized EBITDA: -15253000.00
ICCM income_statement (annual, 2023-12-31) — Normalized Income: -14652000.00
ICCM cash_flow (annual, 2023-12-31) — Operating Cash Flow: -12550000.00
ICCM cash_flow (annual, 2023-12-31) — Operating Gains Losses: -25000.00
ICCM income_statement (annual, 2023-12-31) — Operating Income: -15576000.00
ICCM income_statement (annual, 2023-12-31) — Operating Revenue: 3229000.00
ICCM balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 1553518.00
ICCM income_statement (annual, 2023-12-31) — Other Gand A: 3267000.00
ICCM cash_flow (annual, 2023-12-31) — Other Non Cash Items: -29000.00
ICCM balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 34000.00
ICCM balance_sheet (annual, 2023-12-31) — Other Properties: 2644000.00
ICCM balance_sheet (annual, 2023-12-31) — Other Receivables: 11000.00
ICCM balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 529000.00
ICCM balance_sheet (annual, 2023-12-31) — Payables: 502000.00
ICCM balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 2784000.00
ICCM balance_sheet (annual, 2023-12-31) — Prepaid Assets: 619000.00
ICCM income_statement (annual, 2023-12-31) — Pretax Income: -14652000.00
ICCM cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
ICCM balance_sheet (annual, 2023-12-31) — Properties: 0.00
ICCM cash_flow (annual, 2023-12-31) — Purchase Of Investment: -500000.00
ICCM cash_flow (annual, 2023-12-31) — Purchase Of PPE: -480000.00
ICCM balance_sheet (annual, 2023-12-31) — Raw Materials: 1391000.00
ICCM balance_sheet (annual, 2023-12-31) — Receivables: 228000.00
ICCM income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1929000.00
ICCM income_statement (annual, 2023-12-31) — Reconciled Depreciation: 323000.00
ICCM cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
ICCM income_statement (annual, 2023-12-31) — Research And Development: 8273000.00
ICCM balance_sheet (annual, 2023-12-31) — Restricted Cash: 0.00
ICCM balance_sheet (annual, 2023-12-31) — Retained Earnings: -90061000.00
ICCM income_statement (annual, 2023-12-31) — Salaries And Wages: 4125000.00
ICCM cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
ICCM income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 1211000.00
ICCM income_statement (annual, 2023-12-31) — Selling General And Administration: 8603000.00
ICCM balance_sheet (annual, 2023-12-31) — Share Issued: 1553518.00
ICCM cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1310000.00
ICCM balance_sheet (annual, 2023-12-31) — Stockholders Equity: 12163000.00
ICCM balance_sheet (annual, 2023-12-31) — Tangible Book Value: 12163000.00
ICCM income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ICCM income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
ICCM balance_sheet (annual, 2023-12-31) — Taxes Receivable: 114000.00
ICCM balance_sheet (annual, 2023-12-31) — Total Assets: 16410000.00
ICCM balance_sheet (annual, 2023-12-31) — Total Capitalization: 12163000.00
ICCM balance_sheet (annual, 2023-12-31) — Total Debt: 599000.00
ICCM balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 12163000.00
ICCM income_statement (annual, 2023-12-31) — Total Expenses: 18805000.00
ICCM balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 4247000.00
ICCM balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 2226000.00
ICCM balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 376000.00
ICCM income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -15576000.00
ICCM income_statement (annual, 2023-12-31) — Total Other Finance Cost: -924000.00
ICCM balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
ICCM balance_sheet (annual, 2023-12-31) — Work In Process: 316000.00
ICCM balance_sheet (annual, 2023-12-31) — Working Capital: 10313000.00
ICCM cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 0.00
ICCM balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 3483000.00
ICCM balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 0.00
ICCM cash_flow (quarterly, 2024-09-30) — Purchase Of Investment: 0.00
ICCM cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 837000.00
ICCM income_statement (annual, 2024-12-31) — +Operating Expense: 17147000.00
ICCM income_statement (annual, 2024-12-31) — +Total Revenue: 3291000.00
ICCM balance_sheet (annual, 2024-12-31) — Accounts Payable: 1232000.00
ICCM balance_sheet (annual, 2024-12-31) — Accounts Receivable: 221000.00
ICCM balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1551000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1551000.00
ICCM balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 112280000.00
ICCM balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -3000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -3000.00
ICCM income_statement (annual, 2024-12-31) — Basic Average Shares: 1728374.00
ICCM income_statement (annual, 2024-12-31) — Basic EPS: -8.83
ICCM cash_flow (annual, 2024-12-31) — Beginning Cash Position: 10533000.00
ICCM cash_flow (annual, 2024-12-31) — Capital Expenditure: -71000.00
ICCM balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 459000.00
ICCM balance_sheet (annual, 2024-12-31) — Capital Stock: 0.00
ICCM balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 7564000.00
ICCM balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 7564000.00
ICCM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 9187000.00
ICCM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 446000.00
ICCM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -12563000.00
ICCM cash_flow (annual, 2024-12-31) — Change In Account Payable: 730000.00
ICCM cash_flow (annual, 2024-12-31) — Change In Inventory: 287000.00
ICCM cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 271000.00
ICCM cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -182000.00
ICCM cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 764000.00
ICCM cash_flow (annual, 2024-12-31) — Change In Payable: 730000.00
ICCM cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 730000.00
ICCM cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -237000.00
ICCM cash_flow (annual, 2024-12-31) — Change In Receivables: -118000.00
ICCM cash_flow (annual, 2024-12-31) — Change In Working Capital: 1515000.00
ICCM cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -118000.00
ICCM cash_flow (annual, 2024-12-31) — Changes In Cash: -2930000.00
ICCM balance_sheet (annual, 2024-12-31) — Common Stock: 0.00
ICCM balance_sheet (annual, 2024-12-31) — Common Stock Equity: 6901000.00
ICCM cash_flow (annual, 2024-12-31) — Common Stock Issuance: 9187000.00
ICCM income_statement (annual, 2024-12-31) — Cost Of Revenue: 1840000.00
ICCM balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 847000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 847000.00
ICCM balance_sheet (annual, 2024-12-31) — Current Assets: 10754000.00
ICCM balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 298000.00
ICCM balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 298000.00
ICCM balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 334000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 334000.00
ICCM balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 334000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 334000.00
ICCM balance_sheet (annual, 2024-12-31) — Current Liabilities: 5514000.00
ICCM balance_sheet (annual, 2024-12-31) — Current Provisions: 46000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Current Provisions: 46000.00
ICCM cash_flow (annual, 2024-12-31) — Depreciation: 332000.00
ICCM cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 332000.00
ICCM cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 332000.00
ICCM income_statement (annual, 2024-12-31) — Diluted Average Shares: 1728374.00
ICCM income_statement (annual, 2024-12-31) — Diluted EPS: -8.83
ICCM income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -15318000.00
ICCM income_statement (annual, 2024-12-31) — EBIT: -15696000.00
ICCM income_statement (annual, 2024-12-31) — EBITDA: -15364000.00
ICCM cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -39000.00
ICCM cash_flow (annual, 2024-12-31) — End Cash Position: 7564000.00
ICCM cash_flow (annual, 2024-12-31) — Financing Cash Flow: 9187000.00
ICCM balance_sheet (annual, 2024-12-31) — Finished Goods: 349000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Finished Goods: 349000.00
ICCM cash_flow (annual, 2024-12-31) — Free Cash Flow: -12634000.00
ICCM income_statement (annual, 2024-12-31) — General And Administrative Expense: 8912000.00
ICCM balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 224000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 224000.00
ICCM balance_sheet (annual, 2024-12-31) — Gross PPE: 3327000.00
ICCM income_statement (annual, 2024-12-31) — Gross Profit: 1451000.00
ICCM balance_sheet (annual, 2024-12-31) — Inventory: 1988000.00
ICCM balance_sheet (annual, 2024-12-31) — Invested Capital: 6901000.00
ICCM cash_flow (annual, 2024-12-31) — Investing Cash Flow: 446000.00
ICCM cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 9187000.00
ICCM cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
ICCM balance_sheet (annual, 2024-12-31) — Leases: 212000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Leases: 212000.00
ICCM balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 161000.00
ICCM balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 161000.00
ICCM cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
ICCM cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
ICCM balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 575000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 575000.00
ICCM cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 9187000.00
ICCM cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 39000.00
ICCM income_statement (annual, 2024-12-31) — Net Income: -15318000.00
ICCM income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -15318000.00
ICCM income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -15318000.00
ICCM income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -15318000.00
ICCM income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -15318000.00
ICCM cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -15318000.00
ICCM income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -15318000.00
ICCM income_statement (annual, 2024-12-31) — Net Interest Income: 378000.00
ICCM cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 529000.00
ICCM cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
ICCM cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
ICCM cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
ICCM income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 378000.00
ICCM cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -12000.00
ICCM cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: -2000.00
ICCM balance_sheet (annual, 2024-12-31) — Net PPE: 1776000.00
ICCM cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -71000.00
ICCM balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 6901000.00
ICCM income_statement (annual, 2024-12-31) — Normalized EBITDA: -15364000.00
ICCM income_statement (annual, 2024-12-31) — Normalized Income: -15318000.00
ICCM cash_flow (annual, 2024-12-31) — Operating Cash Flow: -12563000.00
ICCM cash_flow (annual, 2024-12-31) — Operating Gains Losses: 39000.00
ICCM income_statement (annual, 2024-12-31) — Operating Income: -15696000.00
ICCM income_statement (annual, 2024-12-31) — Operating Revenue: 3291000.00
ICCM balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 1921749.00
ICCM income_statement (annual, 2024-12-31) — Other Gand A: 4649000.00
ICCM balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 46000.00
ICCM balance_sheet (annual, 2024-12-31) — Other Properties: 2540000.00
ICCM balance_sheet (annual, 2024-12-31) — Other Receivables: 31000.00
ICCM balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
ICCM balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 0.00
ICCM balance_sheet (annual, 2024-12-31) — Payables: 1232000.00
ICCM balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 2079000.00
ICCM balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2757000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2757000.00
ICCM balance_sheet (annual, 2024-12-31) — Prepaid Assets: 793000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 793000.00
ICCM income_statement (annual, 2024-12-31) — Pretax Income: -15318000.00
ICCM cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
ICCM cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
ICCM balance_sheet (annual, 2024-12-31) — Properties: 0.00
ICCM balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
ICCM cash_flow (annual, 2024-12-31) — Purchase Of Investment: -1373000.00
ICCM cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
ICCM cash_flow (annual, 2024-12-31) — Purchase Of PPE: -71000.00
ICCM balance_sheet (annual, 2024-12-31) — Raw Materials: 1408000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Raw Materials: 1408000.00
ICCM balance_sheet (annual, 2024-12-31) — Receivables: 409000.00
ICCM income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1840000.00
ICCM income_statement (annual, 2024-12-31) — Reconciled Depreciation: 332000.00
ICCM cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
ICCM income_statement (annual, 2024-12-31) — Research And Development: 7096000.00
ICCM balance_sheet (annual, 2024-12-31) — Retained Earnings: -105379000.00
ICCM income_statement (annual, 2024-12-31) — Salaries And Wages: 4263000.00
ICCM cash_flow (annual, 2024-12-31) — Sale Of Investment: 1902000.00
ICCM cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
ICCM income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 1139000.00
ICCM income_statement (annual, 2024-12-31) — Selling General And Administration: 10051000.00
ICCM balance_sheet (annual, 2024-12-31) — Share Issued: 1921749.00
ICCM cash_flow (annual, 2024-12-31) — Stock Based Compensation: 869000.00
ICCM balance_sheet (annual, 2024-12-31) — Stockholders Equity: 6901000.00
ICCM balance_sheet (annual, 2024-12-31) — Tangible Book Value: 6901000.00
ICCM income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ICCM income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
ICCM balance_sheet (annual, 2024-12-31) — Taxes Receivable: 157000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 157000.00
ICCM balance_sheet (annual, 2024-12-31) — Total Assets: 12576000.00
ICCM balance_sheet (annual, 2024-12-31) — Total Capitalization: 6901000.00
ICCM balance_sheet (annual, 2024-12-31) — Total Debt: 459000.00
ICCM balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 6901000.00
ICCM income_statement (annual, 2024-12-31) — Total Expenses: 18987000.00
ICCM balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 5675000.00
ICCM balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1822000.00
ICCM balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 161000.00
ICCM income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -15696000.00
ICCM income_statement (annual, 2024-12-31) — Total Other Finance Cost: -378000.00
ICCM income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: -46000.00
ICCM balance_sheet (annual, 2024-12-31) — Work In Process: 231000.00
ICCM balance_sheet (quarterly, 2024-12-31) — Work In Process: 231000.00
ICCM balance_sheet (annual, 2024-12-31) — Working Capital: 5240000.00
ICCM income_statement (quarterly, 2025-03-31) — +Operating Expense: 3875000.00
ICCM income_statement (quarterly, 2025-03-31) — +Total Revenue: 725000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 953000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 300000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 114967000.00
ICCM income_statement (quarterly, 2025-03-31) — Basic Average Shares: 1921322.00
ICCM income_statement (quarterly, 2025-03-31) — Basic EPS: -1.80
ICCM cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 7564000.00
ICCM cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -6000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 380000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Capital Stock: 0.00
ICCM balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 6040000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 6040000.00
ICCM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 2562000.00
ICCM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -6000.00
ICCM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -4038000.00
ICCM cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -279000.00
ICCM cash_flow (quarterly, 2025-03-31) — Change In Inventory: -48000.00
ICCM cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 101000.00
ICCM cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -441000.00
ICCM cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 123000.00
ICCM cash_flow (quarterly, 2025-03-31) — Change In Payable: -279000.00
ICCM cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -279000.00
ICCM cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -84000.00
ICCM cash_flow (quarterly, 2025-03-31) — Change In Receivables: -79000.00
ICCM cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -707000.00
ICCM cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -79000.00
ICCM cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1482000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Common Stock: 0.00
ICCM balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 6000000.00
ICCM cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 2562000.00
ICCM income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 507000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Current Assets: 9441000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 272000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 272000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 4996000.00
ICCM cash_flow (quarterly, 2025-03-31) — Depreciation: 89000.00
ICCM cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 89000.00
ICCM cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 89000.00
ICCM income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 1921322.00
ICCM income_statement (quarterly, 2025-03-31) — Diluted EPS: -1.80
ICCM income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -3588000.00
ICCM income_statement (quarterly, 2025-03-31) — EBIT: -3657000.00
ICCM income_statement (quarterly, 2025-03-31) — EBITDA: -3568000.00
ICCM cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -42000.00
ICCM cash_flow (quarterly, 2025-03-31) — End Cash Position: 6040000.00
ICCM cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 2562000.00
ICCM cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -4044000.00
ICCM income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 922000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1618000.00
ICCM income_statement (quarterly, 2025-03-31) — Gross Profit: 218000.00
ICCM income_statement (quarterly, 2025-03-31) — Interest Income: 69000.00
ICCM income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 69000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Inventory: 2036000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Invested Capital: 6000000.00
ICCM cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -6000.00
ICCM cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 2562000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 108000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 108000.00
ICCM cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 2562000.00
ICCM cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 43000.00
ICCM income_statement (quarterly, 2025-03-31) — Net Income: -3588000.00
ICCM income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -3588000.00
ICCM income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -3588000.00
ICCM income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -3588000.00
ICCM income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -3588000.00
ICCM cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -3588000.00
ICCM income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -3588000.00
ICCM income_statement (quarterly, 2025-03-31) — Net Interest Income: 69000.00
ICCM cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
ICCM income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 69000.00
ICCM cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 1000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Net PPE: 1618000.00
ICCM cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -6000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 6000000.00
ICCM income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -3568000.00
ICCM income_statement (quarterly, 2025-03-31) — Normalized Income: -3588000.00
ICCM cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -4038000.00
ICCM cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 43000.00
ICCM income_statement (quarterly, 2025-03-31) — Operating Income: -3657000.00
ICCM income_statement (quarterly, 2025-03-31) — Operating Revenue: 725000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1991298.00
ICCM balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 3771000.00
ICCM income_statement (quarterly, 2025-03-31) — Other Gand A: 922000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 45000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Other Properties: 1618000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1065000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Payables: 953000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 953000.00
ICCM income_statement (quarterly, 2025-03-31) — Pretax Income: -3588000.00
ICCM cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -6000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Receivables: 1365000.00
ICCM income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 507000.00
ICCM income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 89000.00
ICCM income_statement (quarterly, 2025-03-31) — Research And Development: 1664000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -108967000.00
ICCM income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1289000.00
ICCM income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2211000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Share Issued: 1991298.00
ICCM cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 125000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6000000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 6000000.00
ICCM income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ICCM income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
ICCM balance_sheet (quarterly, 2025-03-31) — Total Assets: 11104000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 6000000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Total Debt: 380000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 6000000.00
ICCM income_statement (quarterly, 2025-03-31) — Total Expenses: 4382000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 5104000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1663000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 108000.00
ICCM income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -3657000.00
ICCM income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -69000.00
ICCM balance_sheet (quarterly, 2025-03-31) — Working Capital: 4445000.00
ICCM income_statement (quarterly, 2025-06-30) — +Operating Expense: 3516000.00
ICCM income_statement (quarterly, 2025-06-30) — +Total Revenue: 525000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1161000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 122000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 115222000.00
ICCM cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 6040000.00
ICCM cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -22000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 360000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
ICCM balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 5383000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 5383000.00
ICCM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 2085000.00
ICCM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -23000.00
ICCM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -2811000.00
ICCM cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 208000.00
ICCM cash_flow (quarterly, 2025-06-30) — Change In Inventory: -293000.00
ICCM cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 72000.00
ICCM cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -35000.00
ICCM cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 396000.00
ICCM cash_flow (quarterly, 2025-06-30) — Change In Payable: 208000.00
ICCM cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 208000.00
ICCM cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -121000.00
ICCM cash_flow (quarterly, 2025-06-30) — Change In Receivables: 178000.00
ICCM cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 405000.00
ICCM cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 178000.00
ICCM cash_flow (quarterly, 2025-06-30) — Changes In Cash: -749000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
ICCM balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2891000.00
ICCM cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 85000.00
ICCM income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 394000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Current Assets: 9020000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 301000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Current Debt: 2010000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2311000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 7639000.00
ICCM cash_flow (quarterly, 2025-06-30) — Depreciation: 62000.00
ICCM cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 62000.00
ICCM cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 62000.00
ICCM income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -3364000.00
ICCM income_statement (quarterly, 2025-06-30) — EBIT: -3385000.00
ICCM income_statement (quarterly, 2025-06-30) — EBITDA: -3323000.00
ICCM cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 92000.00
ICCM cash_flow (quarterly, 2025-06-30) — End Cash Position: 5383000.00
ICCM cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 2085000.00
ICCM cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -2833000.00
ICCM income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2674000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1521000.00
ICCM income_statement (quarterly, 2025-06-30) — Gross Profit: 131000.00
ICCM income_statement (quarterly, 2025-06-30) — Interest Income: 21000.00
ICCM income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 21000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Inventory: 2329000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Invested Capital: 4901000.00
ICCM cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -23000.00
ICCM cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 85000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 59000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 59000.00
ICCM cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 85000.00
ICCM cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -94000.00
ICCM income_statement (quarterly, 2025-06-30) — Net Income: -3364000.00
ICCM income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -3364000.00
ICCM income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -3364000.00
ICCM income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -3364000.00
ICCM income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -3364000.00
ICCM cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -3364000.00
ICCM income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -3364000.00
ICCM income_statement (quarterly, 2025-06-30) — Net Interest Income: 21000.00
ICCM cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
ICCM income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 21000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Net PPE: 1521000.00
ICCM cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -22000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2891000.00
ICCM income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -3323000.00
ICCM income_statement (quarterly, 2025-06-30) — Normalized Income: -3364000.00
ICCM cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -2811000.00
ICCM cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -94000.00
ICCM income_statement (quarterly, 2025-06-30) — Operating Income: -3385000.00
ICCM income_statement (quarterly, 2025-06-30) — Operating Revenue: 525000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1994039.00
ICCM balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 2010000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 4167000.00
ICCM income_statement (quarterly, 2025-06-30) — Other Gand A: 626000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 48000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Other Properties: 1521000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1186000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Payables: 1161000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1161000.00
ICCM income_statement (quarterly, 2025-06-30) — Pretax Income: -3364000.00
ICCM cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -22000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Receivables: 1308000.00
ICCM income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 394000.00
ICCM income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 62000.00
ICCM income_statement (quarterly, 2025-06-30) — Research And Development: 1711000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -112331000.00
ICCM income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: -869000.00
ICCM income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1805000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Share Issued: 1994039.00
ICCM cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 170000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2891000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2891000.00
ICCM income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ICCM income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
ICCM balance_sheet (quarterly, 2025-06-30) — Total Assets: 10589000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2891000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Total Debt: 2370000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2891000.00
ICCM income_statement (quarterly, 2025-06-30) — Total Expenses: 3910000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 7698000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1569000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 59000.00
ICCM income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3385000.00
ICCM balance_sheet (quarterly, 2025-06-30) — Working Capital: 1381000.00
ICCM income_statement (quarterly, 2025-09-30) — +Operating Expense: 4113000.00
ICCM income_statement (quarterly, 2025-09-30) — +Total Revenue: 850000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1151000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 104000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 125496000.00
ICCM cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 5383000.00
ICCM cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -3000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 288000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Capital Stock: 0.00
ICCM balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 4971000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 10005000.00
ICCM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 7467000.00
ICCM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -5003000.00
ICCM cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -2705000.00
ICCM cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -10000.00
ICCM cash_flow (quarterly, 2025-09-30) — Change In Inventory: -382000.00
ICCM cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 78000.00
ICCM cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 277000.00
ICCM cash_flow (quarterly, 2025-09-30) — Change In Payable: -10000.00
ICCM cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -10000.00
ICCM cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 350000.00
ICCM cash_flow (quarterly, 2025-09-30) — Change In Receivables: 18000.00
ICCM cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 148000.00
ICCM cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 18000.00
ICCM cash_flow (quarterly, 2025-09-30) — Changes In Cash: -241000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Common Stock: 0.00
ICCM balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 9306000.00
ICCM cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 9175000.00
ICCM income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 573000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Current Assets: 13656000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 264000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 264000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 5748000.00
ICCM cash_flow (quarterly, 2025-09-30) — Depreciation: 73000.00
ICCM cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 73000.00
ICCM cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 73000.00
ICCM income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -3859000.00
ICCM income_statement (quarterly, 2025-09-30) — EBIT: -3836000.00
ICCM income_statement (quarterly, 2025-09-30) — EBITDA: -3763000.00
ICCM cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -171000.00
ICCM cash_flow (quarterly, 2025-09-30) — End Cash Position: 4971000.00
ICCM cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 7467000.00
ICCM cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -2708000.00
ICCM income_statement (quarterly, 2025-09-30) — General And Administrative Expense: -290000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1373000.00
ICCM income_statement (quarterly, 2025-09-30) — Gross Profit: 277000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Inventory: 2711000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Invested Capital: 9306000.00
ICCM cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -5003000.00
ICCM cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 9175000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 24000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 24000.00
ICCM cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 9175000.00
ICCM cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 170000.00
ICCM income_statement (quarterly, 2025-09-30) — Net Income: -3859000.00
ICCM income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -3859000.00
ICCM income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -3859000.00
ICCM income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -3859000.00
ICCM income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -3859000.00
ICCM cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -3859000.00
ICCM income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -3859000.00
ICCM income_statement (quarterly, 2025-09-30) — Net Interest Income: -23000.00
ICCM cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -5000000.00
ICCM income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -23000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Net PPE: 1373000.00
ICCM cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -3000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 9306000.00
ICCM income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -3763000.00
ICCM income_statement (quarterly, 2025-09-30) — Normalized Income: -3859000.00
ICCM cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -2705000.00
ICCM cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 170000.00
ICCM income_statement (quarterly, 2025-09-30) — Operating Income: -3836000.00
ICCM income_statement (quarterly, 2025-09-30) — Operating Revenue: 850000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 2298773.00
ICCM balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 4333000.00
ICCM income_statement (quarterly, 2025-09-30) — Other Gand A: 1758000.00
ICCM cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -44000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 49000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Other Properties: 1373000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Other Receivables: 836000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 5034000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Payables: 1151000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1151000.00
ICCM income_statement (quarterly, 2025-09-30) — Pretax Income: -3859000.00
ICCM cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -5000000.00
ICCM cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -3000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Receivables: 940000.00
ICCM income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 573000.00
ICCM income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 73000.00
ICCM income_statement (quarterly, 2025-09-30) — Research And Development: 1762000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -116190000.00
ICCM cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
ICCM income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 2641000.00
ICCM income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2351000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Share Issued: 2298773.00
ICCM cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 807000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 9306000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 9306000.00
ICCM income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ICCM income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
ICCM balance_sheet (quarterly, 2025-09-30) — Total Assets: 15078000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 9306000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Total Debt: 288000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 9306000.00
ICCM income_statement (quarterly, 2025-09-30) — Total Expenses: 4686000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 5772000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1422000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 24000.00
ICCM income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -3836000.00
ICCM balance_sheet (quarterly, 2025-09-30) — Working Capital: 7908000.00
ICCM income_statement (annual, 2025-12-31) — +Operating Expense: 16320000.00
ICCM income_statement (quarterly, 2025-12-31) — +Operating Expense: 4816000.00
ICCM income_statement (annual, 2025-12-31) — +Total Revenue: 3379000.00
ICCM income_statement (quarterly, 2025-12-31) — +Total Revenue: 1279000.00
ICCM balance_sheet (annual, 2025-12-31) — Accounts Payable: 863000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 863000.00
ICCM balance_sheet (annual, 2025-12-31) — Accounts Receivable: 331000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 331000.00